NCT00445809View on ClinicalTrials.gov

Evaluation of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Early and Evolving Acute Kidney Injury

CompletedOBSERVATIONAL
Enrollment

355

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

April 30, 2009

Conditions
Kidney Failure, Acute
Trial Locations (11)

Unknown

St. Anthony's Central Hospital, Denver

George Washington University, Washington D.C.

Maine Medical Center, Portland

Beth Israel Deaconess Medical Center, Boston

Massachusetts General Hospital, Boston

St. Peters Healthcare, Albany

New York Methodist, Brooklyn

Cleveland Clinic Foundation, Cleveland

University of Pittsburgh, Pittsburgh

University of Texas, Houston, Houston

University of British Columbia, Vancouver

All Listed Sponsors
lead

Abbott RDx Cardiometabolic

OTHER

NCT00445809 - Evaluation of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Early and Evolving Acute Kidney Injury | Biotech Hunter | Biotech Hunter